Welcome to our dedicated page for BHG news (Ticker: BHG), a resource for investors and traders seeking the latest updates and insights on BHG stock.
The BHG news page on Stock Titan functions as a historical archive for announcements related to the business that evolved into NeueHealth, Inc. Company communications describe NeueHealth as a value-driven healthcare company that aligns the interests of health consumers, providers, and payors to support high-quality, coordinated care. Over time, these releases trace the shift from a publicly traded structure to a privately held company acquired by an affiliate of New Enterprise Associates (NEA).
Readers can review earnings releases in which NeueHealth reports financial results, discusses Adjusted EBITDA performance, and highlights metrics such as value-based consumers served and enablement services lives. These updates also describe the company’s activity across the ACA Marketplace, Medicare, Medicaid, and ACO REACH arrangements, and explain how its value-driven, consumer-centric care model is applied in these programs.
The archive also includes transaction announcements, such as the December 23, 2024 disclosure of a definitive merger agreement with an NEA affiliate and the October 2, 2025 announcement of the closing of that take-private transaction. Other items include corporate updates like the acquisition of the remaining equity interest in Centrum Health, described as one of NeueHealth’s value-driven clinic brands.
By following this news history, users can see how the company presented its strategy, care model, and financial progress, as well as the steps leading to the cessation of public trading and transition to private ownership. This makes the BHG news page a useful resource for understanding the company’s evolution, rather than a source of ongoing, real-time updates.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Bright Health Group (NYSE: BHG) has announced it will report its First Quarter financial results on May 9, 2023, before the markets open, followed by a conference call at 8:00 AM Eastern Time. The company focuses on providing value-driven healthcare to aging and underserved consumers through its Fully Aligned Care Model in major markets including Florida, Texas, and California.
Participants can join the call by pre-registering via a provided link, and a webcast will also be available on the company’s Investor Relations page. Bright Health Group is dedicated to making healthcare accessible and affordable, aiming to address the needs of 26% of the aging U.S. population.
Bright Health Group, Inc. (BHG) reported Q4 2022 revenue of $551.4 million, with a net loss of $188.2 million. For the full year 2022, revenue totaled $2.4 billion, with a net loss of $638 million. The company aims for adjusted EBITDA profitability in 2023, despite lowering revenue expectations due to finalized accounting for value-based care contracts. Bright Health reported over $150 million in cash as of February 24, 2023, but breached liquidity covenants, requiring amendments to its credit agreements. Key metrics show growth in commercial and Medicare Advantage consumers, indicating a focus on value-driven care.
Bright Health Group, Inc. (NYSE: BHG) will report its Fourth Quarter financial results on March 1, 2023, before market opening. A conference call is scheduled for 8:00 AM Eastern Time on the same day, with pre-registration available for telephone participants. The company focuses on providing technology-enabled, value-driven healthcare for aging and underserved consumers through its Fully Aligned Care Model, primarily in Florida, Texas, and California, which together represent a significant portion of the U.S. aging population. Investors can access the earnings call via Bright Health's Investor Relations page.
Bright Health Group (NYSE: BHG) has increased its 2023 enterprise revenue guidance to
Bright Health Group (NYSE: BHG) announced that CEO Mike Mikan will present at the 41st Annual J.P. Morgan Healthcare Conference on January 11, 2023, starting at 6:00 p.m. ET in San Francisco, CA. The event will be available via live webcast, with a replay accessible on Bright Health’s Investor Relations page afterwards. Bright Health is dedicated to serving aging and underserved consumers, focusing on unmet clinical needs through a technology-enabled, value-based healthcare model in key markets such as Florida, Texas, and California.
Bright Health Group (NYSE: BHG) received a notice from the NYSE indicating non-compliance with listing standards due to its stock price being below $1.00 over a consecutive 30-day period ending December 2, 2022. The Company has a six-month period to regain compliance, during which its stock will continue to trade. Options include a potential reverse stock split pending stockholder approval. Non-compliance does not affect ongoing operations or SEC reporting requirements, but failure to meet the minimum price may lead to delisting procedures.
